NC State researchers led by Ke Cheng, PhD, created a therapeutic approach that mimics the receptor that the virus binds to and then traps the virus before it infect cells….

Faculty, Press Releases

James F. Howard Jr., MD, Distinguished Professor in the UNC Department of Neurology, was principal investigator of the promising phase 3 trial for the experimental drug efgartigimod.

Press Releases, School of Medicine

Results from the Novavax phase III clinical trial for its COVID-19 vaccine show an overall efficacy of 90%, and demonstrate 100% protection against moderate and severe disease. The study enrolled…

The new $38-million National Institutes of Health consortium – led at UNC-Chapel Hill by Yun Li, PhD – will develop better ways to use polygenic risk scores in diverse communities…

Faculty